RMMI Corp. Provides Corporate Update and Files Annual Information Form
CALGARY, Alberta, October 11, 2018 - RMMI Corp. (CSE: RMMI) ("RMMI" or the "Company") (CSE:RMMI) today announced that it has voluntarily filed its Annual Information Form ("AIF") for the fiscal year ended December 31, 2017 on SEDAR at www.sedar.com.
The Company is also pleased to provide an update on its hemp cultivation program. In February 2018, RMMI received its license to produce industrial hemp at its cultivation and production facility in the County of Newell, two hours east of Calgary. The Company subsequently purchased its first train of aeroponics cultivation equipment from AEssence Corporation. RMMI's objective is to utilize industrial hemp, which is almost genetically identical to marijuana, to develop a detailed understanding of the use of its aeroponics equipment, to hone its standard operating procedures and fine-tune its quality assurance plan, in advance of receiving a license to produce marijuana under Health Canada's Access to Cannabis for Medical Purposes Regulations (Canada).
Hemp cultivation was initiated by germinating hemp seeds at the Company's facility. The time from germination to harvesting of approximately 80 large and healthy plants in RMMI's aeroponics cultivation system was nine weeks. Actual plant growth to maturity took eight weeks.
RMMI's CEO Earl Connors, commented, "The successfully-completed hemp cultivation cycle enabled the Company to collect valuable information including nutrient and pH requirements at different stages of growth, to work on standardisation of environmental conditions such as temperature, humidity, lighting, electroconductivity of the nutrient-water mix, and other factors. RMMI is applying this information in a new hemp cultivation program now underway, to enhance its use and knowledge of its aeroponics equipment and further refine its procedures and quality program."
About RMMI Corp.
RMMI is an Alberta-based company focused on the production, cultivation and sale of medical marijuana in various forms. RMMI, through its wholly-owned subsidiary, Rocky Mountain is a late stage applicant under the Access to Cannabis for Medical Purposes Regulations (Canada) and is in the process of obtaining the requisite license to commence cannabis production and operations. Rocky Mountain blends science with nature using aeroponic cultivation and CO2 extraction. Rocky Mountain intends to produce high-purity, organic-quality cannabis oils. Its team will employ leading, commercially-available science and technology to maximize production yields and product quality as a low-cost producer, while reducing risk to its crops and its business.